# EDGAR Filing Document

**Accession Number:** 0001579982
**File Stem:** 0000940400-26-012614
**Filing Date:** 2026-3
**Character Count:** 16438
**Document Hash:** 8806e7ae9435229b63f7b3c1c5df682b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-012614.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0000940400-26-012614

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260130

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**PERIOD START**: 20260731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ARK ETF Trust
- **CENTRAL INDEX KEY:** 0001579982

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22883
- **FILM NUMBER:** 26820833

**BUSINESS ADDRESS:**
- **STREET 1:** 155 WEST 19TH STREET, FIFTH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011
- **BUSINESS PHONE:** 212.426.7040

**MAIL ADDRESS:**
- **STREET 1:** 155 WEST 19TH STREET, FIFTH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ark ETF Trust
- **DATE OF NAME CHANGE:** 20130624

## Series and Classes Contracts Data

### ARK Genomic Revolution ETF (Series ID: S000042975)

| Class ID   | Class Name                 | Ticker Symbol   |
|:---|:---|:---|
| C000133119 | ARK Genomic Revolution ETF | ARKG            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ARK ETF Trust

- **b. Investment Company Act file number:** 811-22883

- **c. CIK number of Registrant:** 0001579982

- **d. LEI of Registrant:** 2549000Z0EWMH3U0CQ16

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 200 Central Avenue

  - **City:** St. Petersburg

  - **State:** FL

  - **Foreign country:** US

  - **Zip / Postal Code:** 33701

  - **Telephone number:** 727-810-8160

**Item A.2. Information about the Series.**

- **a. Name of Series:** ARK Genomic Revolution ETF

- **b. EDGAR series identifier (if any):** S000042975

- **c. LEI of Series:** 254900EYF7TANB19PE71

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-07-31

- **b. Date as of which information is reported:** 2026-01-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1273636570.28

**Total Liabilities:** $907984.20

**Net Assets:** $1272728586.08

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000133119 | 0.07%                | -7.13%               | 5.09%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $30326424.22             | $-37958390.96                              |
| Month 2  | $22044683.51             | $-113542874.09                             |
| Month 3  | $12734025.11             | $44988007.02                               |

### Schedule of Portfolio Investments

| Name                                                     | Title                                                    | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Prime Medicine Inc                                       | Prime Medicine Inc                                       | CUSIP: 74168J101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   4985424 | NS      | $18994465.44  | 1.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Absci Corp                                               | Absci Corp                                               | CUSIP: 00091E109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |  12019802 | NS      | $35939207.98  | 2.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Veracyte Inc                                             | Veracyte Inc                                             | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |   1097405 | NS      | $41789182.40  | 3.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                              | Incyte Corp                                              | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |    135992 | NS      | $13608719.44  | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp                            | Adaptive Biotechnologies Corp                            | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |   2149231 | NS      | $39760773.50  | 3.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                               | Natera Inc                                               | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |    236502 | NS      | $54665072.28  | 4.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc                                   | Nurix Therapeutics Inc                                   | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1592110 | NS      | $26301657.20  | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings                           | Arcturus Therapeutics Holdings Inc                       | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2613794 | NS      | $19525041.18  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                                | Amgen Inc                                                | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     45055 | NS      | $15403403.40  | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Quantum-Si Inc                                           | Quantum-Si Inc                                           | CUSIP: 74765K105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   7012113 | NS      | $7923687.69   | 0.62%             |  |  |  | No            |                  1 | On Loan: —       |
| Schrodinger Inc/United States                            | Schrodinger Inc/United States                            | CUSIP: 80810D103<br>LEI: 984500044BAE4791E559 | Long             | EC               | CORP              | US        |   2118509 | NS      | $29595570.73  | 2.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Financial Square Treasury Obligations Fund | Goldman Sachs Financial Square Treasury Obligations Fund | CUSIP: 38141W323<br>LEI: 549300C0TCI4VJPGCS21 | Long             | STIV             | RF                | US        |   2675731 | NS      | $2675731.15   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx Inc                                               | CareDx Inc                                               | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |   2126762 | NS      | $43704959.10  | 3.43%             |  |  |  | No            |                  1 | On Loan: No      |
| AtaiBeckley Inc                                          | AtaiBeckley Inc                                          | CUSIP: 04650F101<br>LEI: 529900HOVZ0MXOBQ5Y47 | Long             | EC               | CORP              | US        |   3299659 | NS      | $12406717.84  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals Inc                                | Ionis Pharmaceuticals Inc                                | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |    402154 | NS      | $33246071.18  | 2.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc                                     | Compass Pathways Plc                                     | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |   2145054 | NS      | $14350411.26  | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                                        | Veeva Systems Inc                                        | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |     40948 | NS      | $8350116.16   | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                                    | Beam Therapeutics Inc                                    | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2209480 | NS      | $61025837.60  | 4.79%             |  |  |  | No            |                  1 | On Loan: —       |
| Guardant Health Inc                                      | Guardant Health Inc                                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |    667442 | NS      | $76115085.68  | 5.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp                                    | Twist Bioscience Corp                                    | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |   2229125 | NS      | $91550163.75  | 7.19%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                                         | 10X Genomics Inc                                         | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |   3288358 | NS      | $66424831.60  | 5.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacific Biosciences of Califor                           | Pacific Biosciences of California Inc                    | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |  11140437 | NS      | $25177387.62  | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Standard BioTools Inc                                    | Standard BioTools Inc                                    | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |   3063591 | NS      | $4289027.40   | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| Caris Life Sciences Inc                                  | Caris Life Sciences Inc                                  | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |    407334 | NS      | $9433855.44   | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| 908 Devices Inc                                          | 908 Devices Inc                                          | CUSIP: 65443P102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1976162 | NS      | $12469582.22  | 0.98%             |  |  |  | No            |                  1 | On Loan: —       |
| Personalis Inc                                           | Personalis Inc                                           | CUSIP: 71535D106<br>LEI: 549300EZ2NYFK7H0US48 | Long             | EC               | CORP              | US        |   8329028 | NS      | $78042992.36  | 6.13%             |  |  |  | No            |                  1 | On Loan: No      |
| GeneDx Holdings Corp                                     | GeneDx Holdings Corp                                     | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    205719 | NS      | $19802510.94  | 1.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Cerus Corp                                               | Cerus Corp                                               | CUSIP: 157085101<br>LEI: 254900BIEY9XIDA04Q21 | Long             | EC               | CORP              | US        |   6691243 | NS      | $15590596.19  | 1.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                            | Recursion Pharmaceuticals Inc                            | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |  12153128 | NS      | $50921606.32  | 4.00%             |  |  |  | No            |                  1 | On Loan: —       |
| CRISPR Therapeutics AG                                   | CRISPR Therapeutics AG                                   | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |   2034541 | NS      | $101645668.36 | 7.99%             |  |  |  | No            |                  1 | On Loan: —       |
| Tempus AI Inc                                            | Tempus AI Inc                                            | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |   1755350 | NS      | $105005037.00 | 8.25%             |  |  |  | No            |                  1 | On Loan: —       |
| Intellia Therapeutics Inc                                | Intellia Therapeutics Inc                                | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |   2995166 | NS      | $39386432.90  | 3.09%             |  |  |  | No            |                  1 | On Loan: —       |
| Vertex Pharmaceuticals Inc                               | Vertex Pharmaceuticals Inc                               | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     25948 | NS      | $12192965.20  | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Butterfly Network Inc                                    | Butterfly Network Inc                                    | CUSIP: 124155102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   6229192 | NS      | $24667600.32  | 1.94%             |  |  |  | No            |                  1 | On Loan: —       |
| Illumina Inc                                             | Illumina Inc                                             | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    397493 | NS      | $57560961.33  | 4.52%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-31

**Name of Applicant:** ARK ETF Trust

**Signature:** Bill Cox

**Name of Signer:** Bill Cox

**Title:** Principal Financial Officer